Akebia Therapeutics Inc (AKBA)
1.14
-0.01
(-0.87%)
USD |
NASDAQ |
May 21, 16:00
1.14
0.00 (0.00%)
After-Hours: 17:41
Akebia Therapeutics Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.114M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 20.00M |
| March 31, 2021 | 19.94M |
| December 31, 2020 | 59.68M |
| September 30, 2020 | -49.94M |
| June 30, 2020 | -50.00M |
| March 31, 2020 | 0.245M |
| December 31, 2019 | 22.28M |
| September 30, 2019 | 24.39M |
| June 30, 2019 | 54.03M |
| March 31, 2019 | 110.47M |
| December 31, 2018 | 16.72M |
| September 30, 2018 | 11.01M |
| Date | Value |
|---|---|
| June 30, 2018 | -3.568M |
| March 31, 2018 | 12.43M |
| December 31, 2017 | -8.308M |
| September 30, 2017 | -44.96M |
| June 30, 2017 | -31.69M |
| March 31, 2017 | -92.30M |
| December 31, 2016 | 22.31M |
| September 30, 2016 | 45.57M |
| June 30, 2016 | 29.79M |
| March 31, 2016 | -84.96M |
| December 31, 2015 | 1.638M |
| September 30, 2015 | -14.46M |
| June 30, 2015 | -4.276M |
| March 31, 2015 | 3.405M |
| December 31, 2014 | -7.637M |
| September 30, 2014 | -40.00M |
| June 30, 2014 | -23.08M |
| March 31, 2014 | 5.358M |
| December 31, 2013 | 1.735M |
| September 30, 2013 | -13.16M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-50.00M
Minimum
Jun 2020
59.68M
Maximum
Dec 2020
5.026M
Average
--
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -0.029M |
| Amicus Therapeutics Inc | 7.537M |
| Insmed Inc | 295.32M |
| Altimmune Inc | -39.52M |
| InfuSystems Holdings Inc | -0.418M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.43M |
| Cash from Financing (Quarterly) | 18.48M |
| Free Cash Flow | -25.28M |
| Free Cash Flow Per Share (Quarterly) | -0.0948 |
| Free Cash Flow to Equity (Quarterly) | -14.89M |
| Free Cash Flow Yield | -11.52% |